574 related articles for article (PubMed ID: 22721490)
1. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
[TBL] [Abstract][Full Text] [Related]
2. The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population.
Isordia-Salas I; Olalde-Román MJ; Santiago-Germán D; de la Peña NC; Valencia-Sánchez JS
Thromb Res; 2012 Sep; 130(3):e67-72. PubMed ID: 22819265
[TBL] [Abstract][Full Text] [Related]
3. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Lambert M; Camoin L; Vague IJ; Bonnet JL; Alessi MC
Thromb Res; 2007; 120(6):893-9. PubMed ID: 17337040
[TBL] [Abstract][Full Text] [Related]
4. P2RY12 gene polymorphisms and effect of clopidogrel on platelet aggregation.
Galić E; Vrbanić L; Kapitanović S; Catela Ivković T; Petro D; Vuković I; Bsharat RS; Milicević Z; Vcev A; Mirat J
Coll Antropol; 2013 Jun; 37(2):491-8. PubMed ID: 23940995
[TBL] [Abstract][Full Text] [Related]
5. Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.
Kim KA; Song WG; Lee HM; Joo HJ; Park JY
Thromb Res; 2013 Aug; 132(2):221-6. PubMed ID: 23849096
[TBL] [Abstract][Full Text] [Related]
6. Profile and prevalence of clopidogrel resistance in patients of acute coronary syndrome.
Kumar S; Saran RK; Puri A; Gupta N; Sethi R; Surin WR; Dikshit M; Dwivedi SK; Narain VS; Puri VK
Indian Heart J; 2007; 59(2):152-6. PubMed ID: 19122249
[TBL] [Abstract][Full Text] [Related]
7. P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting.
Zoheir N; Abd Elhamid S; Abulata N; El Sobky M; Khafagy D; Mostafa A
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):525-31. PubMed ID: 23751603
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
Thromb Res; 2005; 116(6):491-7. PubMed ID: 16181985
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
Arya V; Mahajan P; Saraf A; Mohanty A; Sawhney JP; Bhargava M
Int J Lab Hematol; 2015 Dec; 37(6):809-18. PubMed ID: 26264906
[TBL] [Abstract][Full Text] [Related]
10. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
11. Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene.
Staritz P; Kurz K; Stoll M; Giannitsis E; Katus HA; Ivandic BT
Int J Cardiol; 2009 Apr; 133(3):341-5. PubMed ID: 18485500
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
13. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.
Bierend A; Rau T; Maas R; Schwedhelm E; Böger RH
Br J Clin Pharmacol; 2008 Apr; 65(4):540-7. PubMed ID: 17995973
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
[TBL] [Abstract][Full Text] [Related]
15. Impact of initial clinical presentation on clopidogrel low response.
Landel JB; Bauters A; Delhaye C; Bonello L; Sudre A; Susen S; Bauters C; Lablanche JM; Lemesle G
Arch Cardiovasc Dis; 2013 Nov; 106(11):593-600. PubMed ID: 24070598
[TBL] [Abstract][Full Text] [Related]
16. Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel.
Yang HH; Chen Y; Gao CY
Cardiovasc Ther; 2016 Dec; 34(6):460-467. PubMed ID: 27566695
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
Lev EI; Patel RT; Guthikonda S; Lopez D; Bray PF; Kleiman NS
Thromb Res; 2007; 119(3):355-60. PubMed ID: 16581111
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.
Diehl P; Olivier C; Halscheid C; Helbing T; Bode C; Moser M
Basic Res Cardiol; 2010 May; 105(3):379-87. PubMed ID: 19943165
[TBL] [Abstract][Full Text] [Related]
19. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
20. The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients.
Namazi S; Kojuri J; Khalili A; Azarpira N
Biochem Pharmacol; 2012 Apr; 83(7):903-8. PubMed ID: 22265638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]